Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Deogratias Ruhangaza"'
Autor:
Felix Manirakiza, Eric Rutaganda, Hidetaka Yamada, Yuji Iwashita, Belson Rugwizangoga, Benoit Seminega, Vincent Dusabejambo, Gervais Ntakirutimana, Deogratias Ruhangaza, Annette Uwineza, Kazuya Shinmura, Haruhiko Sugimura
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 5, Pp 4359-4374 (2023)
Cancer research in Rwanda is estimated to be less than 1% of the total African cancer research output with limited research on colorectal cancer (CRC). Rwandan patients with CRC are young, with more females being affected than males, and most patient
Externí odkaz:
https://doaj.org/article/c85d6dba9b1245f4ac5eb16752b358ff
Autor:
Parsa Erfani, Michael Bates, Pat Garcia-Gonzalez, Dan A. Milner, Timothy R. Rebbeck, Deogratias Ruhangaza, Lawrence N. Shulman, Temidayo Fadelu
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
Externí odkaz:
https://doaj.org/article/51139f8568d545e2941bb4de56664eb1
Autor:
Cyprien Shyirambere, Chandler Villaverde, Cam Nguyen, Deogratias Ruhangaza, Aline Umwizerwa, Oscar Nsanzimana, Louis Mujyuwisha, Esperance Iradukunda, Lawrence N. Shulman, Leslie Lehmann
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSENephroblastoma is a highly curable pediatric cancer that requires multidisciplinary care. Few reports have assessed long-term treatment outcomes in low-resource settings using a task-shifting model of care. We report outcomes of a large cohort
Externí odkaz:
https://doaj.org/article/177f796e1b06487488475cae5d68930e
Autor:
Jennifer Morgan, Rebecca J. DeBoer, Jean Bosco Bigirimana, Cam Nguyen, Deogratias Ruhangaza, Alan Paciorek, Fred Mugabo, Chandler Villaverde, Nicaise Nsabimana, Pascal Bihizimana, Aline Umwizerwa, Leslie E. Lehmann, Lawrence N. Shulman, Cyprien Shyirambere
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEIn describing our ten-year experience with treating chronic myeloid leukemia (CML) as part of the Glivec Patient Assistance Program (GIPAP) in rural Rwanda, we evaluate (1) patient characteristics and treatment outcomes, (2) resource-adapted m
Externí odkaz:
https://doaj.org/article/86d4371b614f4236be4bbd36557d8cb8
Autor:
Rebecca J. DeBoer, Cyprien Shyirambere, Caitlin D. Driscoll, Yvan Butera, Alan Paciorek, Deogratias Ruhangaza, Temidayo A. Fadelu, Aline Umwizerwa, Jean Bosco Bigirimana, Clemence Muhayimana, Cam Nguyen, Paul H. Park, Tharcisse Mpunga, Leslie Lehmann, Lawrence N. Shulman
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 1093-1102 (2020)
PURPOSE Hodgkin lymphoma (HL) is highly curable in high-income countries (HICs), yet many patients around the world do not have access to therapy. In 2012, cancer care was established at a rural district hospital in Rwanda through international colla
Externí odkaz:
https://doaj.org/article/e25a25fd07eb45fb8b2507a3acbefbec
Autor:
Lydia E. Pace, Lauren E. Schleimer, Cyprien Shyirambere, André Ilbawi, Jean Marie Vianney Dusengimana, Jean Bosco Bigirimana, Francois Regis Uwizeye, Mary Chamberlin, Yeonsoo Sara Lee, Lawrence N. Shulman, Susan Troyan, Benjamin O. Anderson, Catherine Duggan, Daniel S. O’Neil, Allison Dvaladze, Jane Brock, Cam Nguyen, Deogratias Ruhangaza, Olivier Habimana, Nicaise Nsabimana, John Butonzi, Eugene Nkusi, Tharcisse Mpunga, Nancy L. Keating
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 1446-1454 (2020)
PURPOSEThe burden of cancer is growing in low- and middle-income countries (LMICs), including sub-Saharan Africa. Ensuring the delivery of high-quality cancer care in such regions is a pressing concern. There is a need for strategies to identify mean
Externí odkaz:
https://doaj.org/article/5a9fd8e0f9cf48328dbd673415d0cf99
Autor:
Deogratias Ruhangaza, Marcellin C. Mugabe, Catherine N. Kigonya, Andrew A. Lane, Elizabeth A. Morgan
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-6 (2019)
Externí odkaz:
https://doaj.org/article/9ae2456f0c2a471794db31cfa97dfdcd
Autor:
Parsa Erfani, Esther Gaga, Emmanuel Hakizimana, Emmanuel Kayitare, Jean Claude Mugunga, Cyprien Shyirambere, Dan Milner, Lawrence Shulman, Deogratias Ruhangaza, Temidayo Fadelu
Publikováno v:
Bulletin of the World Health Organization. 101:10-19
Publikováno v:
Blood Advances, Vol 1, Iss , Pp 14-17 (2017)
Externí odkaz:
https://doaj.org/article/a0e2088814164d1fb398f38572a25c89
Autor:
Clarisse Musanabaganwa, Jean Baptiste Mazarati, Deogratias Ruhangaza, Nicaise Nsabimana, Emmanuel Kayitare, Thierry Zawadi Muvunyi, Muhammed Semakula, Faustin Ntirenganya, Musoni Emile, Jules Ndoli, Elisee Hategekimana, Angus Nassir, Francis Makhoha, Aline Uwimana, Joel Gasana, Pierre Celestin Munezero, Laetitia Nyirazinyoye, Claude Mambo Muvunyi, Leon Mutesa
Background Breast cancer is the most common cancer in women worldwide and the second leading cause of cancer mortality in Rwanda. The knowledge of hormonal receptors and Human Epidermal growth factor Receptor − 2 (Her-2/Neu) profile remains crucial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e8b667b42d4ae9d18f788505cdf3a7f
https://doi.org/10.21203/rs.3.rs-2820749/v1
https://doi.org/10.21203/rs.3.rs-2820749/v1